Skip to main content

Closed

VYGR: Voyager Therapeutics, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin-349.2%

ROIC-60.9%

Financially safe

Stretched

Debt / equity0.20×

Interest coverage0.0×

Current ratio8.42×

Voyager Therapeutics, Inc.

VYGRNASDAQ Global Select·USD·Closed

Voyager Therapeutics, Inc.

VYGRNASDAQ·USD·Closed

$3.03

−3.19%

$3.03

−$0.10 (3.19%)

52W Range

6thpctl

Volume

0.65×avg

Mkt Cap

183.08MUSD

P/E

-1.5TTM

Div Yield

–ann

52W Range

6thpctl

Volume

0.65×avg

Market Cap

183.08MUSD

P/E Ratio

-1.5TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings